Evaluation of 3D Ultrasound in Brain Tumor Surgery
Neuro3DUS
1 other identifier
interventional
90
1 country
2
Brief Summary
Evaluation of impact of use of 3D ultrasound in brain tumor surgery on extend of resection. Benefit for surgery, neurological outcome, accuracy and image quality are secondary outcome parameters. Control group is a retrospective matched pair cohort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
April 24, 2023
CompletedFirst Posted
Study publicly available on registry
July 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedJuly 24, 2023
July 1, 2023
3.2 years
April 24, 2023
July 13, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Extent of resection
Volumetric assessment of residual T1 contrast enhancement or FLAIR signal changes in enhancing and non-enhancing glioma, respectively.
48 hours after surgery
Secondary Outcomes (3)
image quality
during surgery
neurological outcome
both after surgery and at 3 months
Accuracy of device
during surgery
Other Outcomes (1)
brainshift during surgery
during surgery
Study Arms (2)
prospective arm
EXPERIMENTALUse of 3D ultrasound intraoperative before intraoperative MRI
retrospective matched pair arm
NO INTERVENTIONno use of intraoperative ultrasound before intraoperative MRI
Interventions
Eligibility Criteria
You may qualify if:
- age above 18 suspected intra-axial lesion (metastasis or Glioma) potential gross total resection of lesion
You may not qualify if:
- no ability for informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Ulmlead
- Brainlab AGcollaborator
Study Sites (2)
University of Tübingen
Tübingen, Baden Würtemberg, Germany
University of Ulm
Ulm, Germany
Related Publications (1)
Aleo D, Elshaer Z, Pfnur A, Schuler PJ, Fontanella MM, Wirtz CR, Pala A, Coburger J. Evaluation of a Navigated 3D Ultrasound Integration for Brain Tumor Surgery: First Results of an Ongoing Prospective Study. Curr Oncol. 2022 Sep 15;29(9):6594-6609. doi: 10.3390/curroncol29090518.
PMID: 36135087RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- apl. Prof. Dr. med. Jan Coburger, Consultant
Study Record Dates
First Submitted
April 24, 2023
First Posted
July 24, 2023
Study Start
October 1, 2021
Primary Completion
December 1, 2024
Study Completion
March 31, 2025
Last Updated
July 24, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share